Review on common nanoparticles use in treatment of parasitic infecsion
Keywords:
Parasites, Nanoparticles, Nonetheless, LiposomalAbstract
Parasites are organisms that depend on a host organism for their survival and obtain nutrients from them. They can either live on or inside the host. They have the potential to induce a diverse array of illnesses, spanning from malaria and trypanosomiasis to intestinal worms. Nanoparticles have the potential to revolutionize vaccine development for parasitic infections by improving antigen delivery, adjuvant effects, and overall vaccine efficacy. They provide creative answers to tackle the distinct difficulties presented by parasitic illnesses, getting us nearer to the objective of managing and eradicating these infections. Nonetheless, it is crucial to persist with the exploration and enhancement of nanoparticle-centered parasitic vaccines to guarantee their safety and efficacy. Additionally, it is imperative to navigate the regulatory channels for the authorization and dissemination of these vaccines. One of the most common nanoparticles used in parasitic disease treatment is liposomes. Liposomal drug delivery systems have shown their potential in improving drug solubility, stability, and targeted delivery to infected tissues. This has led to improved drug efficacy while minimizing side effects. Liposomal formulations have been successfully employed in the treatment of a range of parasitic diseases, such as leishmaniasis, malaria, and trypanosomiasis.
Downloads
References
Assafa, D.; Kibru, E.; Nagesh, S.; Gebreselassie, S. ; Deribe, F.; Ali, J. (2004). Medical Parasitology University of Gondar Ethiopia Public Health Training Initiative, The Carter Center, the Ethiopia Ministry of Health, and the Ethiopia Ministry of Education
Benelli, G. (2018) Gold nanoparticles: against parasites and insect vectors Acta Tropica. Volume 178, February 2018, Pages 73–80
Capela, R.; Moreira, R.; and Lopes, F. (2019). An Overview of Drug Resistance in Protozoal Diseases Int J Mol Sci. 2019 Nov; 20(22): 5748.
Gedda, M.; Madhukar, P.; Vishwakarma, A. K.; Verma, V.; Kushwaha, A. K.; Yadagiri, G.; Mudavath, S. L.; Sigh, O. P. Srivastava, O.N.; Sundar, S. (2020) Evaluation of Safety and Antileishmanial Efficacy of Amine-Functioned Carbon-Based Composite Nanoparticles Appended With Amphotericin B: An In Vitro and Preclinical Study Medicinal and Pharmaceutical Chemistry, Volume 8
Jaracz, S.; Chen, JOURNAL; Kuznetsova, L. V.; and Ojima, I. (2005). Recent advances in tumor-targeting anticancer drug conjugates Bioorg. Med. Chem., 13: 5043–5054.
Kannan, D.; Yadav, N.; Ahmad, S.; Namdev, P.; Bhattacharjee, S.; Lochab, B. (2019). Pre-clinical study of iron oxide nanoparticles fortified with artesunate for efficient targeting of malarial parasites eBiomedicine, Vol. 45, P261-277.
Landfear ,S.M.(2011). Nutrient Transport and Pathogenesis in Selected Parasitic Protozoa Eukaryot Cell, Vol. 10(4): 483–493.
Nair, A. B., & Jacob, S. (2016). A simple practice guide for dose conversion between animals and humans Journal of Basic and Clinical Pharm., 7(2), 27–31.
Nalawade, P.; Aware, B.; Kadam, V. Journal; & Hirlekar, R.S. (2009). Layered double hydroxides: A review Journal Sci. Ind. Res., 68, 267–272.
Pati, R.; Shevtsov, M.; and Sonawane, A. (2018) Nanoparticle vaccines against infectious diseases. Front Immunol. 2018; 9: 2224.
Puri, A.; Loomis, K.; Smith, B.; Lee, J.H. ; Yavlovich, A.; Heldman, E.; Blumenthal, R. (2010). Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic Cret Rev Ther drug carrier. Syst vol. 26 (6): 523-580.
Rai, M.; Kon, K.; Ingle, A.; Duran, N.; Galdiero, S.; and Galdiero, M. (2014). Broad-spectrum bioactivities of silver nanoparticles: emerging trends and future prospects Applied Microbiology and Biotechnology, volume 98, pages 1951–1961.
Shankar, M.; Lavakumar, V.; NiranjaBabu, M.; Rajasekhar, R.V.; Nafees, S.; and Lakshmiteja, T. (2013) Review: importance of nanotechnology in pharmaceutical preparation World Journal of Pharmacy and Pharmaceutical Sciences, 2(6):4573–4581
Sharma, N.; Sinph, V.; and Shyma, K. P. (2015) Role of parasitic vaccines in integrated control of parasitic diseases in livestock, Vet World. 2015 May; 8(5): 590–598.
Sun, Y.; Chen, D.; Pan , Y.; Qu, Y.; Hao, H.; Wang, X.; Liu, Z.; Xei, S. (2019). Nanoparticles for antiparasitic drug delivery Drug Deliv. 2019; 26(1): 1206–1221.
Volpedo, G.; Costal, L. ; Ryan, N. ; Halsey, G.; Satoskar, A.; and Oghumu, S. (2019). Nanoparticulate drug delivery systems for the treatment of neglected tropical protozoan diseases J Venom Anim Toxins incl Trop Dis, 25: e144118.
Wang, A. Z.; Langer, R.; and Farokhzad, O. C. (2012) Nanoparticle delivery of cancer drugs Annu. Rev. Med., 63:185–198.
